Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
SemperVirens Venture Capital, founded in 2018, operates with approximately $300 million in assets under management (AUM). The firm has established a portfolio of over 70 companies, focusing on transformative solutions in health tech, workforce technology, and fintech. SemperVirens is headquartered in the United States and actively invests in startups across China and Israel.
In March 2025, SemperVirens closed two significant funds: the $141 million Core Fund III and the $36 million Growth Opportunity Fund II. These recent fund closures reflect the firm’s commitment to supporting innovative startups that address complex industry challenges. The firm’s proprietary support system, SemperSystem, connects portfolio companies with over 200 Fortune 500 advisors, enhancing their go-to-market strategies and customer acquisition efforts.
SemperVirens Venture Capital targets category-defining startups in the health tech, HR tech, and fintech sectors. The firm invests at various stages, including seed, Series A, Series B, and Series C, with check sizes ranging from $500,000 to $5 million. Their investment strategy emphasizes companies that leverage artificial intelligence to solve significant employer needs and transform complex industries.
The firm seeks to partner with startups that demonstrate strong potential for growth and innovation. SemperVirens values founders who are building solutions that enhance productivity, collaboration, and financial resilience. Their investment thesis focuses on ecosystem-driven capital, utilizing their extensive network of Fortune 500 advisors to facilitate go-to-market acceleration for portfolio companies.
SemperVirens has made a total of 124 investments, with a notable focus on health tech, workforce technology, and fintech. Their portfolio includes companies such as:
These companies exemplify the firm’s commitment to supporting startups that address critical employer needs and drive innovation in their respective fields. The average investment sizes across different stages include $8.17 million for seed, $18.4 million for Series A, $38.8 million for Series B, and $86 million for Series C.
To pitch SemperVirens, founders should prepare a concise pitch deck that includes key information about their business, market opportunity, and team. The preferred channel for submissions is through their website, where founders can also find additional resources and guidelines.
Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions are encouraged, as they can facilitate a more favorable review process.
SemperVirens operates the SemperVirens Venture Capital program, which provides tailored support and resources for portfolio companies. This program connects startups with industry experts and advisors, facilitating go-to-market strategies and customer acquisition.
Eligibility for the program typically includes being a startup in the health tech, HR tech, or fintech sectors, with a focus on leveraging AI for innovation. Founders can apply through the firm’s website for consideration.
On October 14, 2025, SemperVirens made its latest investment, continuing its trend of active capital deployment. In the past 12 months, the firm has completed 9 investments, reflecting its commitment to supporting innovative startups.
In March 2025, SemperVirens closed a $177 million fund, which indicates strong momentum in their investment activities and a focus on accelerating growth for their portfolio companies.
What are SemperVirens' investment criteria?
SemperVirens focuses on category-defining startups in health tech, HR tech, and fintech. They prefer companies that leverage AI to solve complex challenges and enhance productivity.
How can I apply or pitch to SemperVirens?
Founders can reach out through their website or connect with a member of their team for an introduction. A well-prepared pitch deck that outlines the business model, market opportunity, and team is essential.
What makes SemperVirens different from other venture capital firms?
The firm offers access to a unique ecosystem of over 200 Fortune 500 advisors, providing portfolio companies with strategic guidance and support for go-to-market strategies.
What is the geographic scope of SemperVirens' investments?
SemperVirens invests in startups primarily located in the United States, China, and Israel, focusing on companies that operate in their target sectors.
What is the typical fund size and check size for SemperVirens?
SemperVirens recently closed a $177 million fund, with check sizes ranging from $500,000 to $5 million across various investment stages.
What kind of post-investment involvement can founders expect?
SemperVirens actively engages with portfolio companies through their SemperSystem, providing access to advisors and resources that facilitate growth and market entry.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.